Sustained anti-tumor CD4+ T cell “memory-like” formation was also shown in a vaccine trial of prostate cancer patients utilizing the AE37 vaccine and the DR11/AE37 tetramer to identify AE37 specific T cells. Here, CD4 is linked to neoplasm.